Low-grade gastrointestinal lymphoma in dogs: 20 cases (2010 to 2016)

Grants

Funding Acknowledgements

Records of dogs diagnosed between 2010 and 2016 at The University of Tennessee Veterinary Medical Center, Knoxville, TN, USA; The University of Minnesota College of Veterinary Medicine, St. Paul, MN, USA; Veterinary Oncology Consultants, Lake Innes, Australia; BluePearl Veterinary Partners, New York, NY, USA; Oregon State University, Corvallis, OR, USA; University of Adelaide, Adelaide, Australia; Veterinary Specialty Center of Delaware, New Castle, DE, USA; Coral Springs Animal Hospital, Coral Springs, FL, USA; Seattle Veterinary Specialists, Kirkland, WA, USA; Animal Emergency and Referral Associates, Fairfield, NJ, USA; University of Melbourne, Werribee, Victoria, Australia; Melbourne Veterinary Specialist Centre, Glen Waverly, Victoria, Australia; and Summit Veterinary Referral Center, Tacoma, WA, USA were retrospectively reviewed. The authors thank Joshua Lachowicz (BluePearl Veterinary Partners, New York, NY, USA), Anne Peaston (University of Adelaide, Adelaide, Australia), Rachael Gaeta (Veterinary Specialty Center of Delaware, New Castle, DE, USA), Amanda Foskett and Christine Manley (The Oncology Service, Leesburg, VA, USA), Francisco Alvarez (Coral Springs Animal Hospital, Coral Springs, FL, USA), Seth Glasser (Animal Emergency and Referral Associates, Fairfield, NJ, USA), Kate Heading (Melbourne Veterinary Specialist Centre, Glen Waverly, Victoria, Australia), Laura Brockley (Victorian Animal Cancer Care, Melbourne, Victoria, Australia) and Sarah Gillings (Summit Veterinary Referral Center, Tacoma, WA, USA) for contributing cases to this study. The authors also thank the Animal Cancer Care and Research Program at the University of Minnesota College of Veterinary Medicine for providing funding for immunohistochemistry.